INDOCO258.00

Indoco Remedies Limited

· Pharma & Health
₹ CrorePeersSAIPARENTPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,381 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment788.2849.1969.8969.8
+ Capital Work-in-Progress102.9276.128.328.3
+ Goodwill21.521.521.521.5
+ Other Intangibles144.6126.3201.8201.8
+ Intangibles under Development21.944.461.761.7
+ Non-current Investments1.51.51.51.5
+ Long-term Loans3.13.63.33.3
+ Other Non-current Financial Assets6.76.213.113.1
Non-current Financial Assets11.311.317.817.8
+ Other Non-current Assets99.799.899.099.0
Total Non-current Assets1,190.11,428.61,399.91,399.9
Current Assets
+ Inventories353.1419.4405.2405.2
+ Current Investments7.20.00.00.0
+ Trade Receivables406.2352.4489.2489.2
+ Cash & Cash Equivalents14.912.125.925.9
+ Other Bank Balances9.55.07.17.1
+ Short-term Loans1.53.34.74.7
+ Other Current Financial Assets7.03.312.912.9
Current Financial Assets446.2376.1539.7539.7
+ Other Current Assets153.6187.5226.9226.9
Total Current Assets954.71,001.31,193.41,193.4
Total Assets2,144.72,429.92,593.32,593.3
Equity
+ Equity Share Capital18.418.518.518.5
+ Other Equity / Reserves1,091.51,003.6920.8920.8
Equity — Owners of Parent1,109.91,022.0939.3939.3
+ Minority Interest0.6-3.6-7.2-7.2
Total Equity1,110.51,018.4932.1932.1
Liabilities
+ Borrowings — Non-current364.1542.6516.0516.0
+ Other Non-current Financial Liab4.94.445.145.1
Non-current Financial Liabilities369.0547.0561.1561.1
+ Provisions — Non-current33.735.835.735.7
+ Deferred Tax Liabilities11.813.44.44.4
+ Other Non-current Liabilities7.47.47.57.5
Non-current Liabilities421.9603.5608.6608.6
+ Borrowings — Current307.8451.0519.8519.8
+ Trade Payables153.6208.1308.5308.5
+ Other Current Financial Liab88.080.6119.1119.1
Current Financial Liabilities549.5739.7947.4947.4
+ Provisions — Current48.445.246.946.9
+ Other Current Liabilities14.523.258.358.3
Current Liabilities612.3808.01,052.61,052.6
Total Liabilities1,034.21,411.51,661.21,661.2
Total Equity & Liabilities2,144.72,429.92,593.32,593.3
Assets — additional as-filed lines
+ Current Tax Assets1.818.421.621.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current55.990.390.3
+ Dues to Other Creditors — Current152.2218.3218.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.